Search
English

Products tagged with 'influenza'

View as Grid List
Sort by
Display per page
Picture of Comirnaty Bivalent Vaccine

Comirnaty Bivalent Vaccine

「復必泰二價疫苗」適用於預防2019 冠狀病毒病,主要針對Omicron變異病毒株所研發的疫苗加強劑。與原始株疫苗相比,具有更好的免疫原性,對身體作更全面的保護。根據BioNTech早前公佈臨床試驗數據,「復必泰二價疫苗」作為加強劑接種有利於加強對老年人群體的保護,加強接種後1個月的數據顯示,18-55歲成年人的中和抗體提高9.5倍,55歲以上老年人的中和抗體提高13.2倍,能夠提供更好的保護效果。

  • 適用對象:年滿18歲及已接種兩劑新冠滅活疫苗人士
  • *如核酸或抗原檢測結果曾呈陽性人士,也可以在以最後一次檢測陽性起計三至六個月後接種
  • 二人或以上優惠(HK$ 1,388/針),如欲了解詳情,請聯絡客戶服務熱線:22728222
  • HK$1,488.00
    Picture of Quadrivalent Recombinant  Influenza Vaccine (Flublok®)

    Quadrivalent Recombinant Influenza Vaccine (Flublok®)

    Seasonal influenza is an acute illness of the respiratory tract caused by influenza viruses. Influenza occurs in Hong Kong throughout the year but is usually more common in periods from January to March / April and from July to August. It is advised to be vaccinated in autumn.

    It takes about two weeks after vaccination to develop antibody and provide prior protection. COVID-19 vaccines can be co-administered with Influenza vaccine, it also can lower possibility of serious complications and death brought from co-infection by influenza and COVID-19.

    Quadrivalent Recombinant Influenza Vaccine is a recombinant-based quadrivalent influenza vaccines produced by Flublok®. It is suitable for any individual aged 18 years or above. For adults aged 50+, it provides 30% better protection and contain 3 times the amount of HA compared with the traditional influenza vaccines.
    HK$495.00
    Picture of Quadrivalent Influenza Vaccine

    Quadrivalent Influenza Vaccine

    Seasonal influenza is an acute illness of the respiratory tract caused by influenza viruses. Influenza occurs in Hong Kong throughout the year but is usually more common in periods from January to March / April and from July to August. It is advised to be vaccinated in autumn.

    It takes about two weeks after vaccination to develop antibody and provide prior protection. COVID-19 vaccines can be co-administered with Influenza vaccine, it also can lower possibility of serious complications and death brought from co-infection by influenza and COVID-19.
    HK$300.00